New registry aims to find best blood thinner combo for rare clotting disorder

NCT ID NCT05646394

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study collects information from 150 adults with antiphospholipid syndrome who had an artery clot in the past year. Participants are already on one of four blood-thinning treatments. Researchers will track who has another clot or a major bleed over two years to see which treatment works best and is safest.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTIPHOSPHOLIPID SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

antiphospholipid syndrome arterial occlusion Hemorrhage myocardial infarction stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Clinica Universitaria Reina Fabiola

    RECRUITING

    Córdoba, Argentina

    Contact Phone: •••-•••-••••

  • Instituto de Investigaciones en Salud Pública, Universidad de Buenos Aires

    RECRUITING

    Buenos Aires, Buenos Aires F.D., C1113 AAJ, Argentina

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • McMaster University

    RECRUITING

    Hamilton, Ontario, L9H 7M1, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••